The Evolution of Newtyn Management's Holdings: Comparing Q3 2022 to Q4 2022

Newtyn Management, LLC is a renowned investment firm that manages billions of dollars in assets. The firm follows a novel investment philosophy that involves rigorously studying the market and investing in promising companies across industries. Newtyn Management's Q3 2022 and Q4 2022 13F filings have revealed several changes in its portfolio. In this blog post, we will discuss the evolution of Newtyn Management's holdings by comparing the Q3 2022 holdings to the Q4 2022 holdings.

The comparison of the two 13F filings is based on the numbers of shares held, the value of the holdings in dollars, and the percentage change between the two quarters. The holdings comparison summarizes the changes observed in the Q3 and Q4 2022 filings.

One significant change in Newtyn Management's holdings is the increase in its stake in IAC Inc. The firm raised its holdings in the company by 430,000 shares, from 435,000 shares in Q3 to 865,000 shares in Q4. This increase represents a 59.4% change in the value of the holdings in dollar terms, from $24,090,000 to $38,406,000. IAC is a media and internet conglomerate that operates several brands, such as Vimeo, Dotdash, Care.com, and Investopedia, among others.

Another notable change in the portfolio is the surge in holdings of Ardagh Metal Packaging SA (AMBP). Newtyn Management increased its holdings in the company by 993,532 shares, up from 6,318,468 shares in Q3 to 7,310,000 shares in Q4. The dollar value of this increase was $9,580,000, representing a 15% change. Ardagh Metal Packaging is a UK-based packaging company that manufactures products used in the food and beverage, healthcare, and personal care markets.

In contrast, the firm reduced its holdings in Theravance Biopharma Inc (TBPH) by 10,360,860 shares, from 2,495,860 shares in Q3 to 1,450,000 shares in Q4. This decrease represented a 35.7% change in the value of these holdings, from $25,308,000 to $16,269,000. Theravance Biopharma is a biopharmaceutical company that develops and commercializes drugs for the treatment of respiratory and gastrointestinal diseases.

Newtyn Management's Q4 2022 filings also revealed that the firm established new positions in various companies. One of the notable new positions is in Leafly Holdings Inc (LFLYW). The firm invested and purchased 634,640 shares in the company, valued at $108,000. Leafly Holdings is a cannabis-related online marketplace that connects consumers with cannabis dispensaries, products, and cannabis-related news and information.

In conclusion, Newtyn Management's Q4 2022 holdings show an evolution in the firm's investment strategy. The firm increased its stake in IAC and Ardagh Metal Packaging and decreased its stake in Theravance Biopharma. Additionally, the firm acquired a new position in Leafly Holdings. While the comparison between the Q3 and Q4 13F filings does not represent an entirely accurate view of the firm's investments, it demonstrates the firm's changing investment philosophy and provides valuable insights into its investment strategies.